ANTX – an2 therapeutics, inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ANTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/21

06:00 pm

antx

Form 4 AN2 Therapeutics, Inc. For: Nov 19 Filed by: Readnour Robin Shane

Medium Report

Form 4 AN2 Therapeutics, Inc. For: Nov 19 Filed by: Readnour Robin Shane

Report

11/20

04:12 pm

antx

Form 4 AN2 Therapeutics, Inc. For: Nov 18 Filed by: Zakrzewski Joseph S

Medium Report

Form 4 AN2 Therapeutics, Inc. For: Nov 18 Filed by: Zakrzewski Joseph S

Report

11/18

08:52 pm

antx

Form 4 AN2 Therapeutics, Inc. For: Nov 18 Filed by: Easom Eric

Medium Report

Form 4 AN2 Therapeutics, Inc. For: Nov 18 Filed by: Easom Eric

Report

11/14

04:29 pm

antx

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Neutral Report

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Report

11/14

04:18 pm

antx

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC

Neutral Report

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC

Report

11/13

04:25 pm

antx

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: TCG Crossover GP I, LLC

Medium Report

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: TCG Crossover GP I, LLC

Report

11/13

04:05 pm

antx

Form 10-Q AN2 Therapeutics, Inc. For: Sep 30

High Report

Form 10-Q AN2 Therapeutics, Inc. For: Sep 30

Report

11/13

04:02 pm

antx

Form 8-K AN2 Therapeutics, Inc. For: Nov 13

Medium Report

Form 8-K AN2 Therapeutics, Inc. For: Nov 13

Report

11/5

04:57 pm

antx

Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David

Low Report

Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David

Report

11/5

04:51 pm

antx

Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M

Neutral Report

Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M

Report

11/5

04:49 pm

antx

Form 3 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David

Neutral Report

Form 3 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David

Report

11/5

04:06 pm

antx

Form 8-K AN2 Therapeutics, Inc. For: Nov 04

Low Report

Form 8-K AN2 Therapeutics, Inc. For: Nov 04

Report

8/28

04:02 pm

antx

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: Octagon Capital Advisors LP

Neutral Report

Form SC 13G/A AN2 Therapeutics, Inc. Filed by: Octagon Capital Advisors LP

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.